Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
Jaroslav Žák, Isaraphorn Pratumchai, Brett S. Marro, et al.
Science (2024) Vol. 384, Iss. 6702
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients
Divij Mathew, Melina E. Marmarelis, Caitlin Foley, et al.
Science (2024) Vol. 384, Iss. 6702
Open Access | Times Cited: 48
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
Qing Li, Shan Geng, Hao Luo, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 39
Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells
Kevin Wang, Paulina Coutifaris, David Brocks, et al.
Cancer Cell (2024) Vol. 42, Iss. 9, pp. 1582-1597.e10
Closed Access | Times Cited: 10
The role of B2M in cancer immunotherapy resistance: function, resistance mechanism, and reversal strategies
Xiaowen Han, Jiayi Zhang, Weidong Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Dual inhibition of JAK3 and PD-L1 boosts immune response in triple negative breast cancer
Huali Xiang, Binfeng Tu, Xin Feng, et al.
Anti-Cancer Drugs (2025)
Closed Access
Checkpoint receptors in circulating γδ T cells can discern the outcome of cancer immunotherapy
Elisa Catafal Tardos, Lola Dachicourt, María Virginia Baglioni, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
The success of the tumor immunotherapy: neutrophils from bench to beside
Meng Zhu, Ru Jia, Xiaojie Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
STAT3 Sustains Tumorigenicity Following Mutant KRAS Ablation
Stephen D’Amico, Varvara Kirillov, Jingxuan Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Link of TMPRSS2 expression with tumor immunogenicity and response to immune checkpoint inhibitors in cancers
Karthikeyan Subbarayan, Helena Bieber, Chiara Massa, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Combining JAK Inhibitors with Immune Checkpoint Inhibitors: Overcoming Resistance in Cancer Treatment
Hai‐Jing Zhong
MedComm (2025) Vol. 6, Iss. 3
Open Access
Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy
Huan Song, Lin Chen, Xuanxuan Pan, et al.
Cancer Cell (2025) Vol. 43, Iss. 3, pp. 503-518.e10
Open Access
Heterogeneity of Exhausted T Cell Subsets in Responders and Non-Responders Following Checkpoint Inhibition Therapy
Irina Kareva, Clara Pavillet
Research Square (Research Square) (2025)
Closed Access
Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy
Stephen L. Wang, Timothy A. Chan
Cancer Cell (2025)
Closed Access
A Mitochondria‐Related Signature in Diffuse Large B‐Cell Lymphoma: Prognosis, Immune and Therapeutic Features
Zhiwei Zhou, Jiabin Lu, Song‐Bin Guo, et al.
Cancer Medicine (2025) Vol. 14, Iss. 2
Open Access
Classic Hodgkin lymphoma: Pathobiological features that impact emerging therapies
Mohamed Nazem Alibrahim, Annunziata Gloghini, Antonino Carbone
Blood Reviews (2025), pp. 101271-101271
Closed Access
Therapeutic Targeting of the Janus Kinase/Signal Transducer and Activator of Transcription Pathway in Cutaneous T-Cell Lymphoma
Alisha Kashyap, Julia Dai, Xiao Ni
Cancers (2025) Vol. 17, Iss. 4, pp. 568-568
Open Access
MiRNA-21 promotes the migration and proliferation of prostate cancer cells via activating the JAK/STAT pathway
Xin Han, Changjun Lv
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Brusatol Inhibits the Viability of Anaplastic Thyroid Carcinoma Cells by Modulating the JAK1/STAT3 Signaling Pathway
C. Zhang, Runbo Xie, Yuchen Gao, et al.
(2025)
Closed Access
Primary and Acquired Resistance to Immunotherapy with Checkpoint Inhibitors in NSCLC: From Bedside to Bench and Back
Annapaola Mariniello, Maxime Borgeaud, Marc Weiner, et al.
BioDrugs (2025)
Open Access
RecurrentERBB2alterations are associated with esophageal adenocarcinoma brain metastases
Nora Lawson, Lingqun Ye, Chae Yun Cho, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Interferon-γ-stimulated antigen-presenting cancer-associated fibroblasts hinder neoadjuvant chemoimmunotherapy efficacy in lung cancer
Zhengqi Cao, Zhouwenli Meng, Li J, et al.
Cell Reports Medicine (2025), pp. 102017-102017
Open Access
Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancer
Hyein Jeong, Jaemoon Koh, Sehui Kim, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010612-e010612
Open Access
Prediction, prevention, and precision treatment of immune checkpoint inhibitor neurological toxicity using autoantibodies, cytokines, and microbiota
Alberto Vogrig, Marta Dentoni, Irene Florean, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The immunosuppressive role of MDSCs in HCC: mechanisms and therapeutic opportunities
Xiling Liu, Xichun Kang, Haiyan Kang, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Transitional CXCL14+ cancer‐associated fibroblasts enhance tumour metastasis and confer resistance to EGFR‐TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinoma
Weijiao Xu, Haitang Yang, Ke Xu, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 4
Open Access
Page 1 - Next Page

Scroll to top